Sensor-Guided Nicotine Dispenser Lockout for Craving-Based Dosing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Nicotine addiction makes it difficult for smokers and tobacco users to quit despite negative health consequences, as they often rely on nicotine due to biological and psychological dependence, and existing nicotine replacement therapies may not effectively manage cravings or adherence to cessation programs.

Innovation Solution

A smart nicotine replacement therapy (NRT) device equipped with integrated mechanical and biological sensors, a processor, and a lockout mechanism, which uses real-time feedback from sensors to detect nicotine cravings and biomarkers, providing personalized dosage recommendations and adjusting cessation programs to help users manage cravings and adhere to their quit journey.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a lockout mechanism is implemented to control nicotine dispensing, then adherence to cessation program is improved, but device complexity increases

Engineering Contradiction:
Improveadherence to cessation programVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The processor monitors nicotine consumption data and provides real-time feedback by controlling the lockout mechanism. When the user exceeds the prescribed nicotine threshold, the system automatically locks out further dispensing, ensuring adherence to the cessation program without requiring manual intervention.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system automatically determines when to lock out the dispenser based on pre-programmed cessation guidelines and real-time consumption tracking. The lockout mechanism operates autonomously according to the processor's determination, reducing the need for external monitoring or manual adjustment.

Inventive Principle:
Principle #25Self-service

2Reliability

If real-time sensor feedback is used to detect nicotine cravings and adjust dosages, then effectiveness of nicotine replacement therapy is improved, but device complexity increases

Engineering Contradiction:
Improveeffectiveness of nicotine replacement therapyVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Biological sensors continuously monitor biomarkers indicative of nicotine cravings in real-time. The processor analyzes this data and dynamically adjusts the nicotine dosage dispensed, creating a closed-loop system that adapts to the user's physiological state to optimize therapy effectiveness.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces manual assessment and mechanical dosing adjustment with automated biological sensing and electronic control. Sensors detect physiological markers, and the processor translates this data into precise dosage control, eliminating the need for manual intervention in monitoring and adjustment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If personalized dosage recommendations are provided based on biomarker data, then adherence to quit journey is improved, but loss of time for data processing increases

Engineering Contradiction:
Improveadherence to quit journeyVSAvoidtime for data processing
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system pre-processes and stores cessation program parameters, dosage guidelines, and threshold values in memory before they are needed. When biomarker data is received, the processor quickly compares it against pre-established criteria and immediately determines the appropriate response, minimizing processing delay.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The processor autonomously performs real-time data analysis and dosage determination without requiring external computation or manual review. The system self-manages the entire workflow from biomarker detection to dosage recommendation, streamlining the process and reducing time loss.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20210337881A1Nicotine Replacement Therapy Smart Device
Publication Date: 2021.11.04 MCNEIL AB
  • US20210337881A1 patent drawing
  • US20210337881A1 patent drawing
  • US20210337881A1 patent drawing

AI summary

A device for providing nicotine replacement therapy may be provided. The device may comprise a dispenser for dispensing a nicotine formulation. The device may comprise an actuating member mounted to actuate the dispenser. The device may comprise a lockout mechanism that may be movable between an operative position that may allow the actuating member to move so as to actuate the dispenser, and a non-operative position that may prevent the actuating member from moving. The device may comprise a processor. The processor may be configured to determine an amount of nicotine that was previously consumed by a user. The processor may be configured to send a lockout mechanism signal to the lockout mechanism that causes the lockout mechanism to move to the non-operative position.